Abstract

Four ammonium and imidazolium ionic liquids (ILs) have been synthesized and screened against the T98G cell line (brain cancer) and HEK normal cells. Treatment induced metabolic cell death (MTT), growth inhibition, clonogenic inhibition were studied as cellular response parameters. Treatment with ILs enhanced growth inhibition and cell death in a concentration dependent manner in both the T98G and HEK cell lines. At higher concentrations (>0.09 mg/mL) the cytotoxic effects of the ILs were highly significant. An inhibitory effect on clonogenic capacity was also observed after cell treatment. Amongst all ILs; IL 4 (BMIMCl) exhibited potent activity against T98G brain cancer cells. Despite potent in-vitro activity, all ILs exhibited less cytotoxicity against the normal human HEK cells at all effective concentrations.

Highlights

  • In the race to synthesize new pharmceutical drugs, ionic liquids (ILs) have attracted a great deal of attention amongst in the scientific community due to their variety of potential pharmaceutical applications

  • The data obtained by the metabolic cell death (MTT) assay show that ILs 1, 2, 3 and 4 had inhibitory effects on the growth of T98G

  • These ILs were more efficacious on T98G cancer cells and less toxic to Human Embryonic Kidney (HEK)

Read more

Summary

Introduction

In the race to synthesize new pharmceutical drugs, ionic liquids (ILs) have attracted a great deal of attention amongst in the scientific community due to their variety of potential pharmaceutical applications. Enzymes suspended in the ILs could be reused three times, with less than 10% loss of activity per cycle without influencing enantioselectivity [22] Based on these interesting properties, ILs appear ready to provide a new research outlook in the field of medicinal chemistry. Cytotoxicity of the synthesized ILs on normal cells were assessed using the HEK cell line, which resembles developing neuron and neuronal stem cells and is mentioned as a good model for neuroscience studies [25] Based on this background, we have used HEK normal cells as a model for brain normal cells in this study

Synthesis
MTT Assay
Growth Kinetics Assay
Clonogenic Assay
In Silico Pharmacokinetics
General
Preparation of ILs 1–4
Human Cell Culture
In Vitro Metabolic Viability Assay
In Silico Pharmacokinetic Screening
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.